The anti-proliferative gene TIS21 is involved in osteoclast differentiation
Related Experiment Video
Updated: Jul 27, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Soo Woong Lee1, Han Bok Kwak, Hong Chan Lee
1National Research Laboratory for Bone Metabolism, Research Center for Proteineous Materials, Chosun University, Gwangju.
Abstract:
The remodeling process of bone is accompanied by complex changes in the expression levels of various genes. Several approaches have been employed to detect differentially-expressed genes in regard to osteoclast differentiation. In order to identify the genes that are involved in osteoclast differentiation, we used a cDNAarray-nylon membrane. Among 1,200 genes that showed a measurable signal, 19 genes were chosen for further study. Eleven genes were up-regulated; eight genes were downregulated. TIS21 was one of the up-regulated genes which were highly expressed in mature osteoclasts. To verify the cDNA microarray results, we carried out RT-PCR and real-time RT-PCR for the TIS21 gene. The TIS21 mRNA level was higher in differentiated-osteoclasts when compared to undifferentiated bone-marrow macrophages. Furthermore, the treatment with 1 mM of a TIS21 antisense oligonucleotide reduced the formation of osteoclasts from the bone-marrow-precursor cells by approximately 30%. These results provide evidence for the potential role of TIS21 in the differentiation of osteoclasts
Insights
This study identifies TIS21 as a gene highly expressed in mature osteoclasts. Inhibiting TIS21 with an antisense oligonucleotide significantly reduced osteoclast formation, suggesting its crucial role in bone remodeling.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Bone remodeling involves complex gene expression changes.
- Identifying genes in osteoclast differentiation is crucial for understanding bone diseases.
Purpose of the Study:
- To identify genes involved in osteoclast differentiation using cDNA microarray.
- To investigate the specific role of TIS21 in osteoclastogenesis.
Main Methods:
- cDNA microarray analysis of 1,200 genes.
- RT-PCR and real-time RT-PCR for TIS21 validation.
- Inhibition of TIS21 using antisense oligonucleotides.
Main Results:
- 19 differentially expressed genes were identified, with 11 up-regulated and 8 down-regulated.
- TIS21 showed high expression in mature osteoclasts and increased mRNA levels post-differentiation.
- TIS21 inhibition reduced osteoclast formation by approximately 30%.
Conclusions:
- TIS21 is significantly upregulated during osteoclast differentiation.
- TIS21 plays a functional role in osteoclast formation.
- TIS21 is a potential therapeutic target for bone remodeling disorders.
Related Concept Videos
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

